Mike and Sofia Segal Foundation Gift Expands First-in-Human Trial for Leukemia at CU Anschutz
Jun 9, 2026 Benefactor Spotlight Gift Announcement Office of Advancement Patient Care Research & InnovationThe newly established Mike and Sofia Segal Foundation CMML Research Fund, supported by a $1.5 million commitment, will enable a first-in-human, FDA-cleared CD64 CAR T-cell clinical trial for acute myeloid leukemia and chronic myelomonocytic leukemia at the Gates Institute on the CU Anschutz campus.